Article Details
Retrieved on: 2021-03-12 18:12:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche reported that its arthritis drug Actemra (tocilizumab), when paired with the antiviral remdesivir (Veklury) from Gilead Sciences, did not meet the ...
Article found on: www.fdanews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here